Axplora's consolidation marks a pivotal shift in pharmaceutical production in India.
The increased demand for UDCA highlights urgent healthcare needs worldwide.
Local economies are set to benefit from increased employment opportunities.
Regulatory compliance remains a critical factor in pharmaceutical manufacturing.
Axplora's strategy reflects a broader trend towards localized production.